Diphenylacetyl-D-Arg-4-hydroxybenzylamide is a synthetic peptide analog used to investigate aromatic and basic residue impacts on binding. Its bulky substituents enable steric analysis. Researchers explore its conformational flexibility to assess ligand interactions. The molecule supports peptide modification studies.
CAT No: N05042
CAS No:159013-54-4
Synonyms/Alias:BIBP3226;BIBP 3226;159013-54-4;BIBP-3226;(2R)-5-(diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-N-[(4-hydroxyphenyl)methyl]pentanamide;CHEMBL332347;MFCD00938562;(2R)-5-(diaminomethylideneamino)-2-[[2,2-di(phenyl)acetyl]amino]-N-[(4-hydroxyphenyl)methyl]pentanamide;[3H]BIBP3226;[3H]-BIBP3226;N2-(Diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-D-arginine amide;SCHEMBL650331;GTPL1485;GTPL3474;RG9766UGZ8;DTXSID30415502;BDBM50060728;EX-A11236;AKOS034831590;HY-107726A;FB107864;CS-0078220;Q4835633;(R)-2-(2,2-diphenylacetamido)-5-guanidino-N-(4-hydroxybenzyl)pentanamide;(R)-2-Diphenylacetylamino-5-guanidino-pentanoic acid 4-hydroxy-benzylamide;(R)-5-(diaminomethyleneamino)-2-(2,2-diphenylacetamido)-N-(4-hydroxybenzyl)pentanamide;(2R)-5-Carbamimidamido-2-(2,2-diphenylethanoylamino)-N-((4-hydroxyphenyl)methyl)pentanamide;Benzeneacetamide, N-[(1R)-4-[(aminoiminomethyl)amino]-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl]-alpha-phenyl-;N-[(1R)-4-[(Aminoiminomethyl)amino]-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl]-alpha-phenylbenzeneacetamide;N-[(1R)]-4-[(Aminoiminomethyl)amino-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl-a-phenylbenzeneacetamide trifluoroacetate;N-[(1R)]-4-[(Aminoiminomethyl)amino-1-[[[(4-hydroxyphenyl)methyl]amino]carbonyl]butyl-alpha-phenylbenzeneacetamide trifluoroacetate;
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More